Overview
Junjie Zhao practices practicing medicine in Chengdu, China.
Mr. Zhao is highly rated in 1 condition, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Pleurisy, and Urothelial Cancer.
He is actively involved in clinical research, co-authoring 22 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Junjie Zhao
Is Junjie Zhao a top-rated expert for Renal Cell Carcinoma (RCC)?
MediFind is an objective health platform that identifies experts based on real-world data. Junjie Zhao is classified as an Advanced expert for Renal Cell Carcinoma (RCC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Junjie Zhao participate in research or clinical trials?
Yes. Junjie Zhao has published 22 articles and abstracts on conditions like Renal Cell Carcinoma (RCC). You can view a list of Junjie Zhao's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Renal Cell Carcinoma (RCC)Mr. Zhao isAdvanced. Learn about Renal Cell Carcinoma (RCC).
- Experienced
- PleurisyMr. Zhao isExperienced. Learn about Pleurisy.
- Urothelial CancerMr. Zhao isExperienced. Learn about Urothelial Cancer.